
Ev3 EVVV announced Thursday that it had successfully completed its merger with FoxHollow Technologies . This comes as no surprise, and we are maintaining our fair value estimate for ev3. FoxHollow is now considered a wholly owned
Ev3 EVVV announced Sunday that it will purchase FoxHollow Technologies FOXH for $780 million in cash and stock. We are putting our fair value estimates for both companies under review while we digest the
excellent revenue and profit expansion for Angiotech. Julie Stralow FoxHollow Maintains Estimates (Maintaining) FoxHollow Technologies FOXH reported solid first-quarter operating results May 1. FoxHollow generated $49 million of sales in the
FoxHollow Technologies FOXH reported solid first-quarter operating results Tuesday and maintained its revenue and earnings projections for the full year
Not Great ( Maintaining ) FoxHollow Technologies Poised for Progress ( Maintaining ..... the company. Peter Smith FoxHollow Technologies Poised for Progress (Maintaining) FoxHollow Technologies FOXH reported 2006 revenue that
FoxHollow Technologies FOXH reported 2006 revenue that was in line with our expectations for this medical device firm, with sales growing 51% to reach almost
FoxHollow Technologies FOXH is ending 2006 with a familiar announcement about lowering sales guidance. The company announced that fourth-quarter sales would
Rating for stocks is FoxHollow Technologies FOXH . We estimate the fair ..... Note (11/9/06) FoxHollow Technologies shares fell Thursday ..... Thesis (10/3/06) FoxHollow Technologies aims to change the course
FoxHollow Technologies FOXH shares fell Thursday after reporting excellent third-quarter results, in our opinion, but weak 2006 sales guidance. After
FoxHollow Technologies FOXH announced a particularly advantageous deal extension with Merck MRK Wednesday for the rights to atherosclerotic plaque collected